Literature DB >> 12118554

A comparison of four patient immobilization devices in the treatment of prostate cancer patients with three dimensional conformal radiotherapy.

P Y Song1, M Washington, F Vaida, R Hamilton, D Spelbring, B Wyman, J Harrison, G T Chen.   

Abstract

PURPOSE: To determine the variability of patient positioning during three-dimensional conformal radiotherapy (3D-CRT) for prostate cancer treated with no immobilization or one of four immunobilization devices, and to determine the effects of patient body habitus and pelvic circumference on patient movement with each individual inmobilization technique. METHODS AND MATERIALS: To see whether our immobilization techniques have improved day-to-day patient movement, a retrospective analysis was carried out. A total of 62 patients treated at one facility on a single machine with 3D-CRT via a four-field box technique (anterior-posterior and opposed laterals) in the supine position with either no immobilization or one of four immobilization devices. Five groups of patients were compared: (a) group 1-no immobilization; (b) group 2-alpha cradle from the waist to upper thigh; (c) group 3-alpha cradle from waist to below the knees; (d) group 4-styrofoam leg immobilizer (below knees); and (e) group 5-aquaplast cast encompassing the entire abdomen and pelvis to midthigh with alpha cradle immobilization to their lower legs and feet. Prior to starting radiotherapy, portal films of all four treatment fields were obtained 1 day before treatment. Subsequently, portal films were then obtained at least once a week. Portal films were compared with the simulation films and appropriate changes were made and verified on the next day prior to treatment. A deviation of greater than 0.5 cm or greater was considered to be clincally significant in our analysis. We studied the difference among the types of immobilization and no immobilization by looking at the frequency of movements (overall, and on each of the three axes) that a patient had during the course of his treatment. Using a logistic regression model, the probability of overall and individual directional movement for each group was obtained. In addition, the effects of patient body habitus and pelvic circumference on movement were analyzed.
RESULTS: The maximum deviation was 2 cm and the median deviation was 1.2 cm. For each patient, the probability of movement ranged from 0 to 76%, with a mean of 39%. There was no significant difference seen in overall movement with any of the immobilzation devices compared to no immobilization, but there was less vertical (9 vs. 18%; p = 0.03) and AP (6 vs. 15%; p = 0.14) movement with the aquaplast than any other group. However, when examining the lateral direction, the aquaplast had significantly more movement (32 vs. 9%; p < 0.001). When accounting for body habitus and pelvic circumference, no immobilization device was effective in reducing movement in obese patients or in patients with pelvic circumference greater than 105 cm. The aquaplast group had a significantly increased amount of lateral movement with obesity (42 vs. 23%; p < 0.05), and with pelvic circumference >105 cm (33 vs. 29%; p < 0.05).
CONCLUSIONS: There was no significant reduction in overall patient movement noted with any of the immobilization devices compared to no immobilization. The aquaplast group had reduced vertical and AP movement of greater than 0.5 cm. There was significantly more lateral movement with aquaplast appreciated in obese patients or patients with pelvic circumferences greater than 105 cm. The aquaplast immobilization appears to be useful in reducing movement in two very clinicaly important dimensions (AP and vertical). Despite our findings, other immobilization may still be useful especially in the treatment of nonobese patients. It is clear that the optimal immobilization technique and patient positioning are yet to be determined.

Entities:  

Mesh:

Year:  1996        PMID: 12118554     DOI: 10.1016/0360-3016(95)02094-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

Authors:  Jason A Efstathiou; Kyounghwa Bae; William U Shipley; Gerald E Hanks; Miljenko V Pilepich; Howard M Sandler; Matthew R Smith
Journal:  Cancer       Date:  2007-12-15       Impact factor: 6.860

Review 2.  Adaptive radiation therapy for prostate cancer.

Authors:  Michel Ghilezan; Di Yan; Alvaro Martinez
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

3.  A gradient feature weighted Minimax algorithm for registration of multiple portal images to 3DCT volumes in prostate radiotherapy.

Authors:  Sudhakar Chelikani; Kailasnath Purushothaman; Jonathan Knisely; Zhe Chen; Ravinder Nath; Ravi Bansal; James Duncan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-01       Impact factor: 7.038

4.  Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?

Authors:  Adam D Melancon; Jennifer C O'Daniel; Lifei Zhang; Rajat J Kudchadker; Deborah A Kuban; Andrew K Lee; Rex M Cheung; Renaud de Crevoisier; Susan L Tucker; Wayne D Newhauser; Radhe Mohan; Lei Dong
Journal:  Radiother Oncol       Date:  2007-09-24       Impact factor: 6.280

5.  Interfractional variability in intensity-modulated radiotherapy of prostate cancer with or without thermoplastic pelvic immobilization.

Authors:  J A Lee; C Y Kim; Y J Park; W S Yoon; N K Lee; D S Yang
Journal:  Strahlenther Onkol       Date:  2013-11-08       Impact factor: 3.621

6.  A comparison of two systems of patient immobilization for prostate radiotherapy.

Authors:  Peter White; Chui Ka Yee; Lee Chi Shan; Lee Wai Chung; Ng Ho Man; Yik Shing Cheung
Journal:  Radiat Oncol       Date:  2014-01-22       Impact factor: 3.481

7.  Setup error analysis in helical tomotherapy based image-guided radiation therapy treatments.

Authors:  Bhagyalakshmi Akkavil Thondykandy; Jamema V Swamidas; Jayprakash Agarwal; Tejpal Gupta; Sarbani G Laskar; Umesh Mahantshetty; Shrinivasan S Iyer; Indrani U Mukherjee; Shyam K Shrivastava; Deepak D Deshpande
Journal:  J Med Phys       Date:  2015 Oct-Dec

8.  Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy.

Authors:  Avinash Badajena; Vijay Parshuram Raturi; Kirti Sirvastava; Hidehiro Hojo; Hajime Ohyoshi; Yanping Bei; Toshiya Rachi; Chen-Ta Wu; Taku Tochinai; Masayuki Okumura; Haiqin Zhang; Hirotaki Kouta; Pragya Verma; Geeta Singh; Abhishek Anand; Anjali Sachan
Journal:  Rep Pract Oncol Radiother       Date:  2020-02-22

9.  Immobilization versus no immobilization for pelvic external beam radiotherapy.

Authors:  Avinash H Udayashankar; Shibina Noorjahan; Nirmala Srikantia; K Ravindra Babu; Sandeep Muzumder
Journal:  Rep Pract Oncol Radiother       Date:  2018-05-17

10.  Accuracy and reproducibility of conformal radiotherapy using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).

Authors:  S Stanley; S Griffiths; M R Sydes; A R Moore; I Syndikus; D P Dearnaley
Journal:  Clin Oncol (R Coll Radiol)       Date:  2008-06-18       Impact factor: 4.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.